Article Information
History
- February 28, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Xavier Verhelst1,2,*,#,
- Leander Meuris3,4,*,
- Roos Colman5,
- Anja Geerts1,2,
- Annelies Van Hecke3,4,
- Hans Van Vlierberghe1,2,& and
- Nico Callewaert3,4,&
- 1Ghent Liver Research Center, Ghent University, Ghent, Belgium
- 2Department of Hepatology and Gastroenterology, Ghent University Hospital, Ghent, Belgium
- 3VIB-Ugent Center for Medical Biotechnology, Technologiepark-Zwijnaarde 75, B-9052 Ghent, Belgium
- 4Department of Biochemistry and Microbiology, Ghent University, Ledeganckstraat 35, B-9000 Ghent, Belgium
- 5Biostatistics Unit, Department of Public Health and Primary Care, Ghent University, Ghent, Belgium
- ↵#Corresponding author Correspondence should be addressed to
Xavier Verhelst, Ghent University Hospital, Corneel Heymanslaan 10, Route 1241, Ghent B-9000, Belgium. Phone: 329-332-2371; Fax: 329-332-4984; E-mail: xavier.verhelst{at}uzgent.be
Posted February 28, 2024.
Validation of a glycomics-based test associated with risk of HCC development in cirrhosis
